Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP569463.RAXDC9_YVwk79f2VOR54YypC_xkxD314TrNxtLHW_vOkU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP569463.RAXDC9_YVwk79f2VOR54YypC_xkxD314TrNxtLHW_vOkU130_assertion type Assertion NP569463.RAXDC9_YVwk79f2VOR54YypC_xkxD314TrNxtLHW_vOkU130_head.
- NP569463.RAXDC9_YVwk79f2VOR54YypC_xkxD314TrNxtLHW_vOkU130_assertion description "[The ristocetin cofactor activity is the most useful test for VWD screening in the general population because it reproduces in vitro the first VWF interactions with its platelet receptor; however other assays are required to identify and classify VWD types.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP569463.RAXDC9_YVwk79f2VOR54YypC_xkxD314TrNxtLHW_vOkU130_provenance.
- NP569463.RAXDC9_YVwk79f2VOR54YypC_xkxD314TrNxtLHW_vOkU130_assertion evidence source_evidence_literature NP569463.RAXDC9_YVwk79f2VOR54YypC_xkxD314TrNxtLHW_vOkU130_provenance.
- NP569463.RAXDC9_YVwk79f2VOR54YypC_xkxD314TrNxtLHW_vOkU130_assertion SIO_000772 16977566 NP569463.RAXDC9_YVwk79f2VOR54YypC_xkxD314TrNxtLHW_vOkU130_provenance.
- NP569463.RAXDC9_YVwk79f2VOR54YypC_xkxD314TrNxtLHW_vOkU130_assertion wasDerivedFrom befree-2016 NP569463.RAXDC9_YVwk79f2VOR54YypC_xkxD314TrNxtLHW_vOkU130_provenance.
- NP569463.RAXDC9_YVwk79f2VOR54YypC_xkxD314TrNxtLHW_vOkU130_assertion wasGeneratedBy ECO_0000203 NP569463.RAXDC9_YVwk79f2VOR54YypC_xkxD314TrNxtLHW_vOkU130_provenance.